
RTT News
<img alt="" height="1" width="1" />
BioMimetic shares slide after FDA committee vote
BusinessWeek
Shares of BioMimetic Therapeutics Inc. dropped Friday, a day after the company said a Food and Drug Administration advisory committee voted in support of both the safety and effectiveness of its Augment bone graft. THE SPARK: The Franklin, Tenn., ...
FDA Has "Concerns" About Proposed BioMimetic Bone DeviceWall Street Journal
BioMimetic's bone graft drug up for review today by FDA panelThe Tennessean
Big test ahead for BioMimeticBizjournals.com
msnbc.com -Business Wire (press release) -MedPage Today
all 75 news articles »
More...